CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,802,168 | +78.5% | 116,344 | +83.6% | 0.00% | – |
| Q1 2024 | $1,009,879 | -35.0% | 63,355 | -31.5% | 0.00% | – |
| Q4 2023 | $1,554,623 | -25.0% | 92,482 | -47.8% | 0.00% | -100.0% |
| Q3 2023 | $2,072,836 | +68.7% | 177,317 | +94.0% | 0.00% | – |
| Q2 2023 | $1,228,497 | -27.7% | 91,406 | -10.8% | 0.00% | -100.0% |
| Q1 2023 | $1,698,919 | +111.0% | 102,468 | +136.7% | 0.00% | – |
| Q4 2022 | $805,324 | +376.5% | 43,297 | +228.8% | 0.00% | – |
| Q3 2022 | $169,000 | 0.0% | 13,170 | -45.5% | 0.00% | – |
| Q2 2022 | $169,000 | -80.2% | 24,145 | -76.5% | 0.00% | – |
| Q1 2022 | $852,000 | +616.0% | 102,770 | +482.8% | 0.00% | – |
| Q4 2021 | $119,000 | -38.7% | 17,633 | -51.9% | 0.00% | – |
| Q3 2021 | $194,000 | -62.1% | 36,624 | -58.9% | 0.00% | – |
| Q2 2021 | $512,000 | +369.7% | 89,012 | +172.6% | 0.00% | – |
| Q4 2020 | $109,000 | -77.7% | 32,654 | -80.2% | 0.00% | – |
| Q3 2020 | $489,000 | +652.3% | 164,702 | +1079.7% | 0.00% | – |
| Q2 2020 | $65,000 | -50.8% | 13,961 | -43.7% | 0.00% | – |
| Q3 2019 | $132,000 | +80.8% | 24,776 | +32.4% | 0.00% | – |
| Q4 2017 | $73,000 | +21.7% | 18,720 | -22.0% | 0.00% | – |
| Q3 2017 | $60,000 | +27.7% | 23,999 | -63.4% | 0.00% | – |
| Q2 2016 | $47,000 | -69.3% | 65,594 | +42.5% | 0.00% | -100.0% |
| Q3 2014 | $153,000 | – | 46,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
| TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
| GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
| MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
| Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
| Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
| Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
| KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
| EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
| CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |